STERIS earns Moderate Buy rating from brokerages
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
STERIS plc carries a "Moderate Buy" consensus from Wall Street brokerages, with five of six analysts recommending the stock and an average 12-month price target of $276.33. The medical equipment maker beat quarterly estimates, posting EPS of $2.94 versus $2.68 expected and revenue of Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context